Corteva Downgraded by J.P. Morgan to Neutral on Valuation Concerns

Thursday, Feb 5, 2026 1:21 pm ET1min read
CTVA--

J.P. Morgan downgraded Corteva to Neutral from Overweight, citing valuation and limited upside despite improving fundamentals in the company's seed business. The bank raised its December 2026 price target to $80 from $76.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet